Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
- Volatility is at a recent 2 week low. A recent low volatility of stock movement within a box range could trigger break through when activities pick up.
- A moving average of short volume ratio is at a recent 2 week low. A lower short volume ratio could be a bullish signal.
|Earning Growth (QoQ)|
|Revenue Growth (QoQ)|
|Held by Institutions %||36%|
|1 Day Vol Adjusted Return||0.2|
|1 Month Vol Adjusted Return||-3.3|
|3 Month Vol Adjusted Return||-4.5|
|6 Month Vol Adjusted Return||-7.9|
|20 Days SMA Price ZScore||-0.3|
|50 Days SMA Price ZScore||-1.0|
|12 -26 Days PPO||-2.1|
|1 Month Average Short Volume Ratio||32.8|
|1 Day Volume Change ZScore||-0.7|
|1 Month Daily Vol||2.4|
HAUPPAUGE, N.Y., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the third quarter of 2021 after the close of trading on Thursday, November 4, 2021. The company’s management team will host a corresponding conference call beginning at 4:30 p.m. Eastern Time on November 4, 2021. Investors interested in listening to the conference call ma
Test Provides Simultaneous Detection of Flu A, Flu B, and SARS-CoV-2HAUPPAUGE, N.Y., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the submission of an Emergency Use Authorization (EUA) application to the Food and Drug Administration (FDA) for the company’s DPP Respiratory Antigen Panel test system. The DPP Respiratory Antigen Panel test system is designed to provide simulta
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4). T2 Biosystems, Inc. (NASDAQ: TTOO) rose 25.8% to $1.09 in pre-market trading after the company announced its T2SARS-CoV-2 panel proved capable of detecting the Mu B.1.621 and Iota B.1.526 variants of the SARS-CoV-2 virus. Affirm Holdings, Inc. (NASDAQ: AFRM) rose 23.5% to $113.73 in pre-market trading after the company reported b
Companies in the news are: UI, CEMI, GAMB, BZ
Chembio Diagnostics Inc (NASDAQ: CEMI) is trading higher Friday after the company announced its launch of commercial distribution of SCOV-2 Ag Detect Rapid Test, a third party COVID-19 antigen assay. Chembio Diagnostics said product inventory is on-hand and immediately available for shipment to customers across the United States. The SCOV-2 Ag Detect Rapid Test provides results in 20 minutes from a nasal swab and requires no instrumentation. “We believe this product is an important addition to o